A 20-Week Study Assessing the Efficacy of Apremilast in Patients with EB Simplex Generalized
A 20-Week Study Assessing the Efficacy of Apremilast in Patients with EB Simplex Generalized
Recruiting · NCT06509984 · Registry updated 2025-02-24Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A 20-Week Study Assessing the Efficacy of Apremilast in Patients with EB Simplex Generalized | Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Skin Abnormalities, Skin and Connective Tissue Diseases, epidermolysis bullosa, epidermolysis bullosa simplex, hereditary disease, hereditary skin disorder, skin disorder, vesiculobullous skin disease | Recruiting | Phase 2 | 2025-02-24 | NCT06509984 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Centre Hospitalier Universitaire de Nice | 229 |
4 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| APHP Hôpital Saint-Louis | Paris | France | 1 |
| APHP Necker-Enfants-Malades | Paris | France | 1 |
| Chu de Nice | Nice | France | 11 |
| Chu de Toulouse | Toulouse | France | 20 |